The treatment of epilepsy in women of reproductive age remains a clinical challenge. While
most women with epilepsy (WWE) require anticonvulsant drugs for adequate control of their …

The use of antiepileptic drugs (AEDs) in pregnancy is associated with an increased risk of
fetal malformations. Although it is known that AEDs may differ with respect to the type of …

Although prenatal exposure to antiepileptic drugs (AEDs) is known to impart relatively higher
risks of major congenital malformations, prospective studies have provided refined data that …

Most infants born to women with epilepsy are healthy, but there are increased risks related
to in utero antiepileptic drug (AED) exposure and seizures. Emerging data from pregnancy …

PURPOSE: To conduct a systematic review and meta-analysis to quantify the incidence of
congenital malformations (CMs) and other pregnancy outcomes as a function of in utero anti …

Abstract Background Many antiepileptic drugs (AEDs) have the potential to cause
teratogenicity. We evaluated eight antiepileptic drugs (AEDs) classified as Federal Drug …

Managing epilepsy during pregnancy is to balance the maternal and fetal risks associated
with uncontrolled seizures against the potential teratogenic effects of antiepileptic drugs …

Prescribing antiepileptic drugs (AEDs) in pregnancy is a challenge to the clinician. A
multitude of questions arise that must be addressed even prior to conception. In women with …

PURPOSE: This study was undertaken to (1) measure the frequency of AED monotherapy or
polytherapy during pregnancy and AED discontinuation prior to pregnancy in a cohort of …

Antiepileptic drugs (AEDs) are prescribed commonly to women of childbearing age. In utero
exposure to some AEDs can have significant cognitive and behavioral consequences for the …